Methyltransferase Inhibitor [EPC]: Side Effects & Safety Data for 1 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Methyltransferase Inhibitor [EPC] includes 1 drugs with a combined 1,323 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
1
Drugs in Class
1,323
Combined Reports
All Methyltransferase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| TAZEMETOSTAT HYDROBROMIDE | TAZVERIK | 1,323 | 158 | 233 | 11.9% |
Common Side Effects in Methyltransferase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Dyskinesia | 421 | 57 |
| Off label use | 386 | 89 |
| Fatigue | 379 | 10 |
| Nausea | 283 | 12 |
| Disease progression | 267 | 44 |
| Hallucination | 266 | 10 |
| Fall | 215 | 51 |
| Death | 202 | 201 |
| Constipation | 201 | 6 |
| Product dose omission issue | 201 | 4 |